GEN Exclusives

More »
New Products

Related to New England Biolabs Receives $1.22M to Develop Enzymatic Reagents for Epigenetic Studies

    • DNA Enrichment Kit
    • New England BioLabs
    • The NEBNext® Microbiome DNA enrichment kit can separate microbial DNA from host DNA. The kit utilizes the MBD2-Fc protein, which can bind to CpG-methylated DNA (including human genomic DNA) with high specificity. The MDB2-Fc protein is attache
    • Sugar Transferase for Glycoproteins
    • Roche
    • An alpha-2,6-sialyltransferase is available for in vitro sialylation of glycoproteins and complex molecules in the form of human monoclonal antibodies. The enzyme, which is offered for research and pilot-scale applications in biopharmaceutical manu
    • Kits for Analyzing Modified Cytosines
    • Cambridge Epigenetix
    • TrueMethyl™ kits provide quantitative, accurate and repeatable single-base resolution sequencing of the modified bases hydroxymethylcytosine (5-hmC) and methylcytosine (5-mC) in genomic DNA. This capability is attributable to the kits’ utiliza
  • Page 1 of 1 (3 items) 1 

Jobs

GEN Jobs powered by HireLifeScience.com connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
 Searching...

Unable to get Jobs Listings.

More »

GEN Poll

More » Poll Results »

Biosimilars

Compared to the original biologics, do you think biosimilars run the risks of being less effective and causing more side effects?